Kettering Medical Center — Biomedical Watch V2

Essais liés8clinical trials

VilleKetteringlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03984448

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
WATCHMAN FLX LAAC Device	Accident vasculaire cérébral	Non applicable	NCT04394546	CHAMPION-AF Clinical Trial	ACTIVE_NOT_RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT04269902	Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study	RECRUITING
Biospecimen Collection	SEP	Phase 2/3	NCT03984448	Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas	ACTIVE_NOT_RECRUITING
Biopsy Procedure	SEP	Phase 2	NCT02143414	Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia	ACTIVE_NOT_RECRUITING
Biopsy Procedure	Cancer	Phase 2/3	NCT04628767	Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer	RECRUITING
Biospecimen Collection	Cancer	Phase 3	NCT04267848	Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])	RECRUITING
Biopsy Procedure	Cancer	Phase 2	NCT06126276	Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)	RECRUITING
Bevacizumab	Cancer	Phase 2	NCT00861705	Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	COMPLETED